| abstract |
A method is provided for treating an ocular inflammatory condition, particularly stromal keratitis induced by Herpes Simplex Virus Type 1 (HSV-1). The method comprises administering a therapeutically effective amount of interleukin-10 to an area within the ocular region of a mammal. Pharmaceutical compositions for the treatment of ocular inflammation, including topical solutions, are also provided. |